Update on the evaluation and treatment of osteogenesis imperfecta
- PMID: 25439022
- DOI: 10.1016/j.pcl.2014.08.010
Update on the evaluation and treatment of osteogenesis imperfecta
Abstract
Osteogenesis imperfecta (OI) is a heritable bone fragility disorder that presents with a wide clinical phenotype spectrum: from perinatal lethality and severe deformities to very mild forms without fractures. Most cases of OI are due to autosomal dominant mutations of the type I collagen genes. A multidisciplinary approach with rehabilitation, orthopedic surgery, and consideration of medical therapy with bisphosphonates underpins current management. Greater understanding of the pathogenesis of OI may lead to novel, therapeutic approaches to help improve clinical symptoms of children with OI in the future.
Keywords: Bisphosphonates; Collagen; Fractures; Osteogenesis imperfecta.
Copyright © 2014 Elsevier Inc. All rights reserved.
Similar articles
-
Osteogenesis imperfecta at the beginning of bone and joint decade.Croat Med J. 2001 Aug;42(4):393-415. Croat Med J. 2001. PMID: 11471191 Review.
-
Osteogenesis imperfecta: practical treatment guidelines.Paediatr Drugs. 2000 Nov-Dec;2(6):465-88. doi: 10.2165/00128072-200002060-00005. Paediatr Drugs. 2000. PMID: 11127846 Review.
-
Osteogenesis imperfecta: questions and answers.Curr Opin Pediatr. 2009 Dec;21(6):709-16. doi: 10.1097/MOP.0b013e328332c68f. Curr Opin Pediatr. 2009. PMID: 19907330 Review.
-
Severe osteogenesis imperfecta Type-III and its challenging treatment in newborn and preschool children. A systematic review.Injury. 2015 Aug;46(8):1440-6. doi: 10.1016/j.injury.2015.04.021. Epub 2015 Apr 22. Injury. 2015. PMID: 25943292 Review.
-
Osteogenesis imperfecta: diagnosis and treatment.Curr Osteoporos Rep. 2014 Sep;12(3):279-88. doi: 10.1007/s11914-014-0225-0. Curr Osteoporos Rep. 2014. PMID: 24964776 Review.
Cited by
-
Demographics and medical burden of osteogenesis imperfecta: a nationwide database analysis.Osteoporos Int. 2024 Jul;35(7):1185-1193. doi: 10.1007/s00198-024-07051-2. Epub 2024 Apr 2. Osteoporos Int. 2024. PMID: 38563961
-
Emerging Landscape of Osteogenesis Imperfecta Pathogenesis and Therapeutic Approaches.ACS Pharmacol Transl Sci. 2024 Jan 2;7(1):72-96. doi: 10.1021/acsptsci.3c00324. eCollection 2024 Jan 12. ACS Pharmacol Transl Sci. 2024. PMID: 38230285 Review.
-
The recombinant BMP-2 loaded silk fibroin microspheres improved the bone phenotype of mild osteogenesis imperfecta mice.PeerJ. 2023 Oct 30;11:e16191. doi: 10.7717/peerj.16191. eCollection 2023. PeerJ. 2023. PMID: 37927786 Free PMC article.
-
Acetabular fracture and central hip dislocation in osteogenesis imperfecta child treated surgically with bone grafts augmented by recombinant human bone morphogenetic protein-2: A rare case report.Int J Surg Case Rep. 2023 Jul;108:108436. doi: 10.1016/j.ijscr.2023.108436. Epub 2023 Jun 22. Int J Surg Case Rep. 2023. PMID: 37392586 Free PMC article.
-
Mesenchymal stem cells in the treatment of osteogenesis imperfecta.Cell Regen. 2023 Feb 2;12(1):7. doi: 10.1186/s13619-022-00146-3. Cell Regen. 2023. PMID: 36725748 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
